// App-Quantinova.ai

: 1 Is a Marker of Alternatively Activated Macrophages and a Therapeutic Target in Interstitial Fibrotic Lung Diseases

Researchers

Presenter

  • M. El Taweel

Principal Investigators

  • H. Walker

  • O. Mekhael

  • M. Vierhout

  • M. Padwal

  • S. Naiel

  • H. Patel

  • P. Parthasarathy

  • J. Imani

  • E. Ayaub

  • A. Naqvi

  • J. A. Hirota

  • N. Hambly

  • M. R. J. Kolb

  • K. Ask

Medical Centers

  • Medicine, Firestone Institute for Respiratory Health, McMaster University and The Research Institute of St. Joe’s Hamilton, Hamilton, ON, Canada,

  • Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada

  • Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada,

  • McMaster University, Hamilton, ON, Canada

  • McMaster University, Hamilton, ON, Canada

  • Pulmonary and Critical care medicine, Brigham and Womens Hospital, Boston, Massachusetts, United States

  • Medicine, McMaster, Hamilton, ON, Canada.

  • Rheumatology, McMaster University, Hamilton, ON, Canada

  • McMaster University, Hamilton, ON, Canada

  • Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada,

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Sarcoidosis

Biomarkers

  • C-C Motif Chemokine Ligand 18

  • Cluster of Differentiation 14

Drug/Treatment

  • Bleomycin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved